Welcome to our dedicated page for Corteva news (Ticker: CTVA), a resource for investors and traders seeking the latest updates and insights on Corteva stock.
Corteva Inc (NYSE: CTVA), a global leader in agriscience innovation, provides this centralized hub for investors and agricultural professionals to track essential company developments. Access verified press releases and news coverage spanning Corteva's seed technology advancements, crop protection solutions, and digital agriculture initiatives.
This resource delivers timely updates on earnings reports, product launches, sustainability efforts, and strategic partnerships. Users gain insights into operational milestones across Corteva's core business segments while maintaining compliance with financial disclosure standards.
Key content categories include regulatory filings, R&D breakthroughs, market expansion announcements, and executive leadership updates. All materials are curated to support informed decision-making without speculative commentary.
Bookmark this page for direct access to Corteva's official communications and third-party analysis of agricultural technology trends impacting the company's performance.
Corteva Agriscience has launched Adavelt™ active, a novel fungicide, in Canada, Australia, and South Korea. This product, which is now approved for commercial sale, represents a new mode of action against crop diseases that threaten yields. Adavelt™ active will be available for lentil crops in Canada for the 2023 growing season. This innovative fungicide has preventative and curative properties, enhancing crop protection and reducing resistance risks. Corteva plans to expand Adavelt's availability in additional countries pending regulatory approvals. The launch reflects Corteva's ongoing commitment to R&D for sustainable agricultural solutions.
Bunge (NYSE: BG), Corteva (NYSE: CTVA), and Chevron (NYSE: CVX) announced a collaboration to introduce proprietary winter canola hybrids aimed at producing low-carbon plant-based oil. This initiative targets the renewable fuels market in the southern United States, creating a sustainable crop rotation for farmers while enhancing soil health. The plan includes a pilot program in the 2022-23 growing season to optimize management practices. Executives from the collaborating companies emphasized the importance of feedstock innovation for advancing a lower-carbon energy future and supporting agricultural productivity.
Corteva Agriscience has announced the commercial launch of Vorceed™ Enlist® corn products, targeting U.S. farmers in high corn rootworm pressure areas within the Corn Belt. This new technology combines three modes of above-ground and below-ground insect protection, incorporating RNAi technology and tolerance to four herbicides for better weed management. Through the exclusive Corteva Horizon Network, select farmers will gain early access to these innovations in 2023, with broader offerings expected by mid-decade. The initiative aims to enhance productivity and profitability for farmers while gathering feedback to improve future product launches.
Corteva (NYSE: CTVA) has solidified its position as a global leader in the Biologicals market by acquiring Symborg, a microbiological technology firm in Spain, and Stoller, an independent Biologicals company in Texas. These acquisitions, announced in late 2022, aim to enhance sustainable farming solutions and are expected to positively impact EBITDA in 2023. Corteva's CEO, Chuck Magro, highlighted the strategic advantage of combining the expertise of both companies with Corteva's innovation capabilities. The biologicals market is projected to grow significantly, making these acquisitions vital to Corteva's growth strategy.
Corteva, Inc. (NYSE: CTVA) announces that CEO Chuck Magro will present at the Bank of America Securities 2023 Global Agriculture & Materials Conference on March 1, 2023, at 8:50 a.m. ET. The presentation will be available via live webcast through the Corteva Investor Relations website. A replay will be provided 24 hours post-event, accessible until June 2, 2023. Corteva is a leading global agriculture company focused on innovative solutions for agriculture challenges, with a diverse range of seed, crop protection, and digital products. More details can be found on the Corteva website.
Corteva (NYSE: CTVA) announced the commercial launch of Optimum GLY canola, an advanced herbicide-tolerant trait technology, for the 2023 planting season in Canada and the United States. This product will be available through Pioneer and Brevant seed brands. Optimum GLY is designed to enhance weed control and provide flexibility in herbicide applications, improving crop management for farmers. The technology aims to address farm-level challenges while supporting global food security. Demonstration trials will be held in Australia in preparation for a full launch in 2024.
Corteva, Inc. (NYSE: CTVA) reported its fourth quarter and full-year 2022 results, highlighting net sales of
Corteva, Inc. (NYSE: CTVA) has declared a quarterly common stock dividend of $0.15 per share, scheduled for payment on March 15, 2023. Shareholders of record as of March 1, 2023 will receive this dividend, reflecting the company's commitment to returning capital to its investors. As a global leader in agriculture, Corteva emphasizes innovation and a diverse portfolio in its operations, which includes seed, crop protection, and digital solutions.
Corteva, Inc. (NYSE: CTVA) will announce its fourth quarter and full year 2022 earnings on February 1, 2023, after market close. A live webcast will follow on February 2, 2023, at 9:00 a.m. ET. The earnings presentation will be available on the Investor Events page, and a replay of the webcast will be accessible until February 3, 2024. Corteva focuses on delivering innovative solutions in agriculture and maximizing productivity for farmers, ensuring progress in the agricultural sector.
Corteva has signed a definitive agreement to acquire Stoller Group for $1.2 billion in cash. Stoller is a leading independent biologicals company with projected 2022 revenues exceeding $400 million and operations across 60+ countries. The acquisition is expected to enhance Corteva's biologicals strategy by providing scale and profitability, and is anticipated to be accretive to both Operating EBITDA and EPS in 2023. This marks Corteva's second biologicals acquisition this year, highlighting its commitment to innovative agricultural solutions.